ABBV Stock Summary and Trading Ideas (Abbvie | NYSE:ABBV)

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

What symbol and exchange does Abbvie shares trade?

Abbvie trades on the NYSE stock market under the symbol ABBV.

What is Abbvie stock price doing today?

As of January 9, 2026, ABBV stock price declined to $220.08 with 6,160,626 million shares trading.

What is Abbvie's Beta?

ABBV has a beta of 0.27, meaning it tends to be less sensitive to market movements. ABBV has a correlation of 0.04 to the broad based SPY ETF.

How much is Abbvie worth?

ABBV has a market cap of $388.75 billion. This is considered a Mega Cap stock.

How much money does Abbvie make?

Last quarter Abbvie reported $16 billion in Revenue and $1.86 earnings per share. This beat revenue expectation by $189 million and exceeded earnings estimates by $.08.

What is the highest and lowest price Abbvie traded in the last 3 year period?

In the last 3 years, ABBV traded as high as $244.81 and as low as $130.96.

What are the top ETFs holding Abbvie?

The top ETF exchange traded funds that ABBV belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.

Is Abbvie (ABBV) a good investment?

ABBV has outperformed the market in the last year with a return of +27.0%, while the SPY ETF gained +19.0%. However, in the most recent history, ABBV shares have underperformed the stock market with its stock returning -3.9% in the last 3 month period and -4.3% for the last 2 week period, while SPY has returned +3.7% and +0.5%, respectively.

What are the support and resistance levels for Abbvie (ABBV)?

ABBV support price is $220.64 and resistance is $227.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ABBV shares will trade within this expected range on the day.